Lung Cancer News

Oncology clinical trials appeared to recover from declines in enrollment and activation during the early phase of the COVID-19 pandemic, according to a study of data from two large academic centers published in Annals of Oncology.

CHICAGO — Among previously untreated patients with metastatic non-small cell lung cancer, nivolumab plus ipilimumab provided durable, long-term clinical benefit at 5-year follow-up compared with chemotherapy.

Ravi Salgia, MD, PhD, spoke with Healio about a study assessing the safety and efficacy of three cycles of neoadjuvant sintilimab plus platinum-doublet chemotherapy compared with two cycles in patients with early-stage lung cancer.

President Joe Biden has appointed Elizabeth M. Jaffee, MD; Mitchel Berger, MD; and Carol L. Brown, MD, FACOG, FACS, to the President’s Cancer Panel, the White House announced in a press release.

In this video, Ravi Salgia, MD, PhD, highlighted two studies that investigated treatment for EGFR-mutated non-small cell lung cancer presented at ASCO Annual Meeting.

In this video, Ravi Salgia, MD, PhD, discussed findings from two studies presented at ASCO Annual Meeting — one investigating immunotherapy and the other targeted therapy — for the treatment of lung cancer.

In this video, Ravi Salgia, MD, PhD, discussed the 2022 Excellence in Teaching Award he received at ASCO Annual Meeting.

Certain racial and ethnic minority patients with cancer experienced worse treatment delays and adverse social and economic effects due to the COVID-19 pandemic than white patients, according to study results published in JAMA Network Open.

Ravi Salgia, MD, PhD, spoke with Healio about findings presented at ASCO Annual Meeting from a FDA pooled analysis of first-line treatment options for patients with PD-L1 advanced non-small cell lung cancer.

In this edition, Incidental respiratory findings on low-dose CT lung cancer screening common; lack of guideline-concordant treatment for early-stage non-small cell lung cancer common; women at greater risk for more severe adverse events from cancer treatments, and more.